AIMT
Royal Bank of Canada’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-61,571
| Closed | -$2.12M | – | 6885 |
|
2020
Q3 | $2.12M | Sell |
61,571
-94,353
| -61% | -$3.25M | ﹤0.01% | 2295 |
|
2020
Q2 | $2.61M | Sell |
155,924
-1,378
| -0.9% | -$23K | ﹤0.01% | 2116 |
|
2020
Q1 | $2.27M | Sell |
157,302
-7,031
| -4% | -$101K | ﹤0.01% | 2063 |
|
2019
Q4 | $5.5M | Sell |
164,333
-5,223
| -3% | -$175K | ﹤0.01% | 1753 |
|
2019
Q3 | $3.55M | Buy |
169,556
+39,778
| +31% | +$833K | ﹤0.01% | 1950 |
|
2019
Q2 | $2.7M | Buy |
129,778
+12,099
| +10% | +$252K | ﹤0.01% | 2127 |
|
2019
Q1 | $2.63M | Buy |
117,679
+29,963
| +34% | +$670K | ﹤0.01% | 2092 |
|
2018
Q4 | $2.1M | Buy |
87,716
+9,939
| +13% | +$238K | ﹤0.01% | 2146 |
|
2018
Q3 | $2.12M | Buy |
77,777
+59,901
| +335% | +$1.63M | ﹤0.01% | 2339 |
|
2018
Q2 | $480K | Buy |
17,876
+413
| +2% | +$11.1K | ﹤0.01% | 3279 |
|
2018
Q1 | $555K | Buy |
17,463
+17,076
| +4,412% | +$543K | ﹤0.01% | 3075 |
|
2017
Q4 | $15K | Sell |
387
-2,882
| -88% | -$112K | ﹤0.01% | 4967 |
|
2017
Q3 | $81K | Buy |
3,269
+3,190
| +4,038% | +$79K | ﹤0.01% | 4425 |
|
2017
Q2 | $1K | Sell |
79
-747
| -90% | -$9.46K | ﹤0.01% | 5720 |
|
2017
Q1 | $19K | Sell |
826
-1,373
| -62% | -$31.6K | ﹤0.01% | 4986 |
|
2016
Q4 | $45K | Buy |
2,199
+2,117
| +2,582% | +$43.3K | ﹤0.01% | 4576 |
|
2016
Q3 | $1K | Buy |
+82
| New | +$1K | ﹤0.01% | 5566 |
|
2016
Q1 | – | Sell |
-20
| Closed | – | – | 5883 |
|
2015
Q4 | $0 | Sell |
20
-380
| -95% | – | ﹤0.01% | 6103 |
|
2015
Q3 | $10K | Buy |
+400
| New | +$10K | ﹤0.01% | 5303 |
|